Pharmacokinetics, metabolism, and excretion of 14 C-labeled belinostat in patients with recurrent or progressive malignancies
Conclusion Mass balance was achieved (~95 % mean recovery), with metabolism identified as the primary route of elimination. Radioactivity was predominantly excreted renally as belinostat metabolites.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Bile | Cancer & Oncology | Drugs & Pharmacology | Investigational New Drugs | Lymphoma | Study | T-cell Lymphoma